Arteriogenesis and Therapeutic Neovascularization
| Arteriogenesis and Therapeutic Neovascularization |
| Autore | Deindl Elisabeth |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (220 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
A-to-I editing
activity-based benefits angiogenesis aortic disease arteriogenesis atherosclerosis blood flow recovery blood flow restriction capillary collateral artery growth collateral growth collateral network effect mechanism Egr-1 endothelial cells epitranscriptome ERK factor VII activating protease femoral artery ligation FGFR-1 GH and eNOS GHAS trial HABP2 hind limb ischemia hyperoxygenation IGF-I inflammation innate immunity isomiRs KCa3.1 KV1.3 lower extremity arterial disease m6A macrophages mast cell matrigel microRNA microRNA-212/132 n/a neo-vascularization neovascularization NO NOTCH oxidative stress and arterial inflammation paraplegia paraspinous compartment PDFG-R pericyte peripheral arterial disease potassium channel rAAV RNA methylation RNA modifications SMC proliferation spinal cord ischemia TAAA TLR2/6 training effects vascular biology vascular homeostasis VEGF vein graft disease VHL loss of function αSM-actin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557495503321 |
Deindl Elisabeth
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Immunology
| Cancer Immunology |
| Autore | Subramanian Subree |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (316 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adaptive immunity
anti-CD20 antibody anti-CTLA-4 anti-PD-1 antibody-dependent cellular cytotoxicity (ADCC) antigen presenting cells antigen-presenting cells Atypical Chemokine Receptor 4 (ACKR4) B cell aplasia BAP1 BiFab bispecific antibody cancer cancer stem cells (CSCs) cancer vaccine CAR T carcinoma CD19-CAR-T CD28 cell therapy chemo-enzymatic approach chemotherapy classical and endemic Kaposi Sarcoma colon cancer colorectal cancer combination immunotherapy CTLA-4 cytotoxicity dendritic cells differentiation DNA methylation epidemiologic studies Fab IDO inhibitor IFN-γ IL-7 IL15 immune checkpoint blockade immune checkpoint inhibitors immune checkpoints immune evasion immunomodulation immunosuppression immunotherapy indoleamine 2,3 dioxygenase 1 inhibitory CAR innate immunity interferon KIR kynurenine pathway m6A melanoma MICA/B mAb multi-state modelling n/a NK cells NKG2D organ transplantation osteoclasts PD-1 PD-L1 primary liver cancer prostate cancer resistance RNA methylation S-adenosylmethionine (SAM) sortase A systemic treatment T cells T-cell priming TCR diversity TIL treatment free interval Treg cells triple negative breast cancer tryptophan 2,3 dioxygenase 2 tumor microenvironment tumor-infiltrating lymphocytes uveal |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557349203321 |
Subramanian Subree
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Epitranscriptomics: The Novel RNA Frontier
| Epitranscriptomics: The Novel RNA Frontier |
| Autore | Nigita Giovanni |
| Pubbl/distr/stampa | Frontiers Media SA, 2019 |
| Descrizione fisica | 1 online resource (127 p.) |
| Collana | Frontiers Research Topics |
| Soggetto topico |
Biotechnology
Civil engineering, surveying & building |
| Soggetto non controllato |
Epitranscriptomics
Psuedourylation RNA RNA Editing RNA methylation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Epitranscriptomics |
| Record Nr. | UNINA-9910557235503321 |
Nigita Giovanni
|
||
| Frontiers Media SA, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||